Senior author Ann Marie Pendergast, Ph.D., and researchers from Duke Cancer Institute found a drug approved to treat leukemia successfully disrupted the ability of HER2-positive breast cancer tumors from colonizing the brain.
Senior author Ann Marie Pendergast, Ph.D., and researchers from Duke Cancer Institute found a drug approved to treat leukemia successfully disrupted the ability of HER2-positive breast cancer tumors from colonizing the brain.